CAMRF Stock: Camurus AB (publ) Stock Price, Analysis & Insights
Get live CAMRF stock price $58.00, comprehensive Camurus AB (publ) stock analysis, charts, news, and expert forecast. Real-time CAMRF stock data and investment insights.
Loading chart data...
Camurus AB (publ) (CAMRF) Overview
Camurus AB (publ) (CAMRF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, CAMRF trades at $58.00 with a market capitalization of 3.45B . Over the past 52 weeks, CAMRF has traded between $55.00 and $71.00 , with the current price positioned at approximately 19% of this range . Th...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 3.45B
- Current price: $58.00
- 52-week range: $55.00 - $71.00
- P/E ratio: 47.93
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Camurus AB (publ) is a pharmaceutical enterprise dedicated to the development and global commercialization of therapeutic solutions for severe and enduring medical conditions. Its operations span across Europe, Australia, the United States, Japan, an...
Company Information
- CEO
- Fredrik Tiberg
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 238
Contact Information
- Website
- https://www.camurus.com
- Address
- Ideon Science Park
- Country
- SE
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 47.9)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Camurus AB (publ) shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Camurus AB (publ)
- ⚠Investors should consider how Camurus AB (publ) fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 47.9) requires strong growth to justify
Market Cap
3.45B
P/E Ratio (TTM)
47.93
Beta
1.06
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare CAMRF with peer companies:
- Price
- $38.89
- Market cap
- 7.83B
- Price
- $9.79
- Market cap
- 2.59B
- Price
- $28.08
- Market cap
- 1.85B
- Price
- $1.60
- Market cap
- 3.50B
- Price
- $1.55
- Market cap
- 2.32B
- Price
- $90.61
- Market cap
- 4.63B
- Price
- $5.22
- Market cap
- 6.06B
- Price
- $3.35
- Market cap
- 4.84B
- Price
- $10.99
- Market cap
- 3.54B
- Price
- $9.41
- Market cap
- 3.19B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.